Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Ramiprin Tab. in Essential Hypertension

NCT00366119 is registered in ClinicalTrials.gov with Pacific Pharmaceuticals as lead sponsor.

NCT NCT00366119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00366119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Clinical Trial to Evaluate the Antihypertensive Efficacy and Safety of Ramiprin Tab. in Essential Hypertension
Lead sponsor
Pacific Pharmaceuticals
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2006
Completion date
June 30, 2007
Enrollment
86
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

essential hypertension